• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; IMPLANTABLE DEVICE Back to Search Results
Model Number G141
Device Problems Device Alarm System (1012); Signal Artifact/Noise (1036); Failure to Capture (1081); High impedance (1291); Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574); High Capture Threshold (3266)
Patient Problem Electric Shock (2554)
Event Date 07/19/2023
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited beeping sound.The field representative turned off one half of the duo device in the hospital.This device remains in service.No adverse patient effects were reported.Additional information was received indicating the crt-d system was explanted.The two right ventricular (rv) leads had exhibited out-of-range pace impedance measurements due to rv lead fracture caused by subclavian crush, resulting in high pacing thresholds, noise, oversensing, and inappropriate shocks delivered by the crt-d.One rv lead also exhibited loss of capture.Tachy therapy was then programed off and the patient was equipped with a lifevest until crt-d extraction could occur.The crt-d was explanted and replaced with a non-boston scientific device.A reportedly four-to-five centimeter un-retrieved fragment of the rv lead apex lead was observed during the explant procedure.There was noted patient discomfort and blood loss, and additional surgical intervention was required.The surgery was completed and a new implantable cardioverter defibrillator (icd) system was implanted.No additional adverse patient effects were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) exhibited beeping sound.The field representative turned off one half of the duo device in the hospital.This device remains in service.No adverse patient effects were reported.Additional information was received indicating the crt-d system was explanted.The two right ventricular (rv) leads had exhibited out-of-range pace impedance measurements due to rv lead fracture caused by subclavian crush, resulting in high pacing thresholds, noise, oversensing, and inappropriate shocks delivered by the crt-d.One rv lead also exhibited loss of capture.Tachy therapy was then programed off and the patient was equipped with a lifevest until crt-d extraction could occur.The crt-d was explanted and replaced with a non-boston scientific device.A reportedly four-to-five centimeter un-retrieved fragment of the rv lead apex lead was observed during the explant procedure.There was noted patient discomfort and blood loss, and additional surgical intervention was required.The surgery was completed and a new implantable cardioverter defibrillator (icd) system was implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN CRT-D
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17553716
MDR Text Key321219348
Report Number2124215-2023-43734
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534553
UDI-Public00802526534553
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/01/2018
Device Model NumberG141
Device Catalogue NumberG141
Device Lot Number115876
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Manufacturer Received03/12/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/13/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age46 YR
Patient SexFemale
-
-